BHI News Section Archives - Page 41 of 1201

News

June 17, 2024

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

BETHESDA, Md., June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor…

Andy

Love0

News

June 17, 2024

Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for…

Andy

Love0

BioTalk with Rich Bendis Podcast

June 17, 2024

Leading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk

Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of…

Andy

Love0

News

June 17, 2024

Leading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk

Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of…

Andy

Love0

News

June 16, 2024

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

GERMANTOWN, MD / ACCESSWIRE / June 14, 2024 / Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to…

Andy

Love0

News

June 16, 2024

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

GAITHERSBURG, Md., June 14, 2024/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that…

Andy

Love0

News

June 14, 2024

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

WASHINGTON, June 13, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised…

Andy

Love0

News

June 13, 2024

TEDCO’s Maryland Innovation Initiative Announces Kulshreshtha as the New Executive Director

COLUMBIA, Md., (June 13, 2024) — The Maryland Innovation Initiative (MII) Board of Directors announces the appointment of Abishek Kulshreshtha…

Andy

Love0

News

June 12, 2024

KeViRx, Inc. Awarded $1.99 Million to Advance Small Molecule Technology for Acute Lung Injury

CHARLOTTESVILLE, VA / ACCESSWIRE / June 11, 2024 / KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced today the receipt of $1.99 million…

Andy

Love0

News

June 12, 2024

Program Updates Unveiled for TEDCO’s Maryland Innovation Initiative

COLUMBIA, Md., (June 11, 2024) — Program Updates Unveiled for TEDCO’s Maryland Innovation Initiative TEDCO, Maryland’s economic engine for technology…

Andy

Love0

BHI News Section

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

Leading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk

Leading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

TEDCO’s Maryland Innovation Initiative Announces Kulshreshtha as the New Executive Director

KeViRx, Inc. Awarded $1.99 Million to Advance Small Molecule Technology for Acute Lung Injury

Program Updates Unveiled for TEDCO’s Maryland Innovation Initiative

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search